Leavitt Partners Future Frame Series: The Value Imperative For The Pharmaceutical Industry

Written By: Leavitt Partners

August 02, 2021

On July 16, Leavitt Partners’ CEO Andrew Croshaw moderated a discussion between Jeremy Bahr, Principal at Leavitt Partners, and Prem Kumar, Senior Advisor to Leavitt Partners, focused on trends in U.S. healthcare that affect the pharmaceutical industry, and how pharmaceutical companies may need to evolve to succeed in a value-driven healthcare environment. 

Read more HERE.